BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

e-Therapeutics plc 

Holland Park, Holland Drive

Newcastle  Tyne  NE2 4LZ  United Kingdom
Phone: 44-0-191-2331317 Fax: 44-0-191-2331303


SEARCH JOBS


Industry
Biotechnology

Segment
Drug Discovery





 Company News
e-Therapeutics plc Announces That Steve Medlicott Has Been Appointed Finance Director 4/7/2014 4:15:25 PM    More...
e-Therapeutics plc Announces Directorate Change 4/7/2014 4:00:19 PM    More...
e-Therapeutics plc Reports Positive Interim Results From UK Phase Ia Trial Of ETS2101 (Dexanabinol) In A Variety Of Solid Tumours 3/31/2014 6:57:21 AM    More...
e-Therapeutics plc Announces Recruitment Resumes Into UK Phase I ETS2101 Cancer Trial 3/26/2014 9:55:55 AM    More...
e-Therapeutics plc Begins Phase I Study Of Oral Formulation Of Anti-Cancer Compound ETS2101 With Healthy Volunteers 2/10/2014 8:33:25 AM    More...
e-Therapeutics plc Temporary Halts Recruitment Into ETS2101 Cancer Trials 1/24/2014 6:20:15 AM    More...
e-Therapeutics plc Provides Update On ETS2101 Phase I Trial In Brain Cancer 1/7/2014 9:08:35 AM    More...
e-Therapeutics plc Release: Therapeutic Area Partnerships Meeting Investigates Solutions To The Disparity Between Improving Science And Declining Returns 11/18/2013 12:15:05 PM    More...
e-Therapeutics plc Starts Phase IIb Trial of ETS6103 in Major Depressive Disorder 10/31/2013 1:55:57 PM    More...
e-Therapeutics plc' Interim Results for the Six Months Ended 31 July 2013 10/16/2013 6:39:41 AM    More...
1234

//-->